MOLN:NASDAQ
Molecular Partners AG
၄.၃၅ US$
၀.၀၀%
(၀.၀၀) 1D
စက် ၄, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
၄.၃၅ US$
High
၄.၃၅ US$
Low
၄.၃၅ US$
Mkt. cap
၁၇.၄၅ ကုဋေ
Avg. vol.
၁.၁၀ ထောင်
Volume
၂.၁၇ ထောင်
52-wk high
၅.၃၆ US$
52-wk low
၃.၅၃ US$
EPS
-၁.၆၉ US$
Beta
၁.၀၂
Shares outstanding
၄.၀၄ ကုဋေ
No. of employees
၁၃၄
Open
၄.၃၅ US$
High
၄.၃၅ US$
Low
၄.၃၅ US$
Mkt. cap
၁၇.၄၅ ကုဋေ
Avg. vol.
၁.၁၀ ထောင်
Volume
၂.၁၇ ထောင်
52-wk high
၅.၃၆ US$
52-wk low
၃.၅၃ US$
EPS
-၁.၆၉ US$
Beta
၁.၀၂
Shares outstanding
၄.၀၄ ကုဋေ
No. of employees
၁၃၄
News stories
From web sources and news partners
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၃ ပတ်
MOLN Q4 2025 Earnings: Narrower-Than-Expected Loss Points to Cost Discipline - Financial Summary
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG